JP2005523709A - インフルエンザおよびパラインフルエンザウイルスの検出のための細胞 - Google Patents

インフルエンザおよびパラインフルエンザウイルスの検出のための細胞 Download PDF

Info

Publication number
JP2005523709A
JP2005523709A JP2003587984A JP2003587984A JP2005523709A JP 2005523709 A JP2005523709 A JP 2005523709A JP 2003587984 A JP2003587984 A JP 2003587984A JP 2003587984 A JP2003587984 A JP 2003587984A JP 2005523709 A JP2005523709 A JP 2005523709A
Authority
JP
Japan
Prior art keywords
virus
influenza
cell
mvllu
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003587984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005523709A5 (https=
Inventor
ユング ティー． ファン
Original Assignee
ユニバーシティ ホスピタルズ オブ クリーブランド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ ホスピタルズ オブ クリーブランド filed Critical ユニバーシティ ホスピタルズ オブ クリーブランド
Publication of JP2005523709A publication Critical patent/JP2005523709A/ja
Publication of JP2005523709A5 publication Critical patent/JP2005523709A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2003587984A 2002-04-25 2003-04-17 インフルエンザおよびパラインフルエンザウイルスの検出のための細胞 Pending JP2005523709A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/133,910 US6610474B1 (en) 2002-04-25 2002-04-25 Cells for detection of influenza and parainfluenza viruses
PCT/US2003/012203 WO2003091459A1 (en) 2002-04-25 2003-04-17 Cells for detection of influenza and parainfluenza viruses

Publications (2)

Publication Number Publication Date
JP2005523709A true JP2005523709A (ja) 2005-08-11
JP2005523709A5 JP2005523709A5 (https=) 2006-01-05

Family

ID=27754313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003587984A Pending JP2005523709A (ja) 2002-04-25 2003-04-17 インフルエンザおよびパラインフルエンザウイルスの検出のための細胞

Country Status (8)

Country Link
US (3) US6610474B1 (https=)
EP (1) EP1497468B1 (https=)
JP (1) JP2005523709A (https=)
AT (1) ATE428810T1 (https=)
AU (1) AU2003228607B2 (https=)
CA (1) CA2483747A1 (https=)
DE (1) DE60327190D1 (https=)
WO (1) WO2003091459A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109313191A (zh) * 2016-05-27 2019-02-05 珀金埃尔默细胞科技德国公司 确定细胞培养物的感染部位的数量的方法

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100233674A1 (en) * 2002-04-25 2010-09-16 University Hospitals Of Cleveland Cells for detection and production of influenza and parainfluenza viruses
US7150965B2 (en) * 2003-04-17 2006-12-19 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses
US6610474B1 (en) * 2002-04-25 2003-08-26 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses
US7129042B2 (en) * 2003-11-03 2006-10-31 Diagnostic Hybrids, Inc. Compositions and methods for detecting severe acute respiratory syndrome coronavirus
US8318423B2 (en) 2004-07-06 2012-11-27 Focus Diagnostics, Inc. Methods and compositions for detecting rhinoviruses
US8084443B2 (en) 2007-10-01 2011-12-27 Longhorn Vaccines & Diagnostics Llc Biological specimen collection and transport system and methods of use
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US20090098527A1 (en) * 2006-09-12 2009-04-16 Fischer Gerald W Biological organism identification product and methods
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
EP2772267B1 (en) * 2007-08-27 2016-04-27 Longhorn Vaccines and Diagnostics, LLC Immunogenic compositions and methods
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
EP2344634A4 (en) 2008-09-24 2012-08-29 Medimmune Llc METHODS OF CELL CULTURE, AND PROPAGATION AND PURIFICATION OF VIRUSES
US8376955B2 (en) * 2009-09-29 2013-02-19 Covidien Lp Spectroscopic method and system for assessing tissue temperature
EP3494989B1 (en) 2012-01-26 2025-07-16 Longhorn Vaccines and Diagnostics, LLC Composite antigenic sequences and vaccines
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
EP3294448A4 (en) 2015-05-14 2018-12-12 Longhorn Vaccines and Diagnostics, LLC Rapid methods for the extraction of nucleic acids from biological samples
EP4036209A1 (en) * 2021-01-29 2022-08-03 Leica Microsystems CMS GmbH Microplate for containing a plurality of samples
CN115015549B (zh) * 2022-07-14 2023-01-13 深圳市卫光生物制品股份有限公司 一种狂犬病疫苗灭活验证的试验方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939253A (en) 1996-04-26 1999-08-17 Diagnostic Hybrids, Inc. Compositions and methods for detecting viral infection
US20020082224A1 (en) * 1997-01-14 2002-06-27 Douglas J. Jolly Non-immunogenic prodrugs and selectable markers for use in gene therapy
US6168915B1 (en) 1998-04-24 2001-01-02 Diagnostic Hybrids, Inc. Mixed cell diagnostic systems
US6610474B1 (en) * 2002-04-25 2003-08-26 University Hospitals Of Cleveland Cells for detection of influenza and parainfluenza viruses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109313191A (zh) * 2016-05-27 2019-02-05 珀金埃尔默细胞科技德国公司 确定细胞培养物的感染部位的数量的方法

Also Published As

Publication number Publication date
EP1497468A4 (en) 2005-09-14
AU2003228607A1 (en) 2003-11-10
DE60327190D1 (de) 2009-05-28
EP1497468A1 (en) 2005-01-19
WO2003091459A1 (en) 2003-11-06
EP1497468B1 (en) 2009-04-15
US6610474B1 (en) 2003-08-26
CA2483747A1 (en) 2003-11-06
US20030203357A1 (en) 2003-10-30
ATE428810T1 (de) 2009-05-15
US6991899B2 (en) 2006-01-31
US20040234947A1 (en) 2004-11-25
AU2003228607B2 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
JP2005523709A (ja) インフルエンザおよびパラインフルエンザウイルスの検出のための細胞
Oldstone et al. Alterations of acetylcholine enzymes in neuroblastoma cells persistently infected with lymphocytic choriomeningitis virus
JP5322636B2 (ja) インフルエンザウイルスの増殖方法
JP2002512815A (ja) 混合細胞診断系
Grief et al. Intracellular localisation of dengue-2 RNA in mosquito cell culture using electron microscopic in situ hybridisation
Nogales et al. Reverse genetics of influenza B viruses
JP2003532429A (ja) ウイルス検出のための混合細胞系
Lewandowski et al. Analysis of a viral agent isolated from multiple sclerosis brain tissue: characterization as a parainfluenzavirus type 1
JP2021136899A (ja) ウイルス増殖方法及びウイルス増殖促進剤の探索方法
US8105767B2 (en) Cells for detection of enteroviruses
US7150965B2 (en) Cells for detection of influenza and parainfluenza viruses
Wagner Cytopathic effects of viruses: a general survey
US20030166168A1 (en) Variant varicella-zoster viruses and methods of use
US20100233674A1 (en) Cells for detection and production of influenza and parainfluenza viruses
CN116348768A (zh) 确定是否存在中和病毒的抗体的方法和筛选化合物中和病毒能力的体外方法
AU2002254715A1 (en) Cells for detection of enteroviruses
US5830638A (en) Cell line and processes for the replicating rabies viruses and detecting them quantitatively
Goto et al. Assays for functional binding of plasminogen to viral proteins
Leland et al. Virus isolation
JPWO2005090549A1 (ja) 細胞培養用マイクロウェル
US7435588B2 (en) Systems for detection and production of respiratory, herpes and enteric viruses
JP2023020424A (ja) シュードタイプウイルス集団及びその製造方法
Li YueTao et al. Packaging of Rift Valley fever virus pseudoviruses and establishment of a neutralization assay method.
FENG Development and characterization of a SARS-coronavirus replicon cell line
Qiu et al. Yuetao Li1, 2, 3, Yongkun Zhao2, Cuiling Wang1, 2, Xuexing Zheng2, 4, Hualei Wang2, Weiwei Gai2, 5, Hongli Jin6, Feihu Yan2

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050705

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080917

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20081216

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20081224

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090115

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090122

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090216

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090226

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090518